Fig. 2From: Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) – comparison between 2004–2006, 2007–2009, and 2010–2012Distribution of the PSA value (ng/mL) at diagnosisBack to article page